A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder

Clinical trial NCT07219966 · RECRUITING

Trial details

NCT number: NCT07219966
Sponsor: Eli Lilly and Company
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Alcohol Use Disorder

Start date: 2025-10-15
Primary completion: 2028-04-01
Enrollment: 1100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.